Primary Progesterone Therapy for Operable Breast Cancer
Status:
Completed
Trial end date:
2020-05-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effect of primary progesterone on overall and
disease free survival in women with operable breast cancer. The study addresses two issues
related to breast cancer surgery:
- Circulating progesterone at the time of surgery might counteract the detrimental effect
of estrogen on survival of women with operable breast cancer.
- Events at the time of surgery may have an impact on the natural history of breast cancer